Aimed Bio IPO Book Building Results Analysis
Aimed Bio finalized its IPO price at 11,000 won, which is at the high end of the IPO price range. Aimed Bio will be listed on KOSDAQ on 4 December....
221 Views
TMC IPO Preview
Korean industrial cable producer TMC set to complete IPO in December 2025, with price range of 8,000 to 9,300 won per share and expected market...
330 Views
ABL Bio: Equity Investment of 22 Billion Won from Eli Lilly
On 14 November, ABLBio (298380 KS) announced that it has signed an equity investment agreement with Eli Lilly & Co (LLY US) worth 22 billion won...
1k Views
LivsMed IPO Valuation Analysis
Our base case valuation of Livsmed is target price of 88,294 won per share, representing a 61% upside from the high end of the IPO price range.
231 Views
CMTX IPO Book Building Results Analysis
CMTX finalized its IPO price at 60,500, the high end of the IPO price range. The book building process saw participation from 2,423 institutions....
454 Views